[1]
Wulandari, F., Ikawati, M., Novitasari, D., Kirihata, M., Kato, J.- ya and Meiyanto, E. 2020. New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells. Indonesian Journal of Pharmacy. 31, 4 (Dec. 2020), 244-256. DOI:https://doi.org/10.22146/ijp.681.